Inside information: Phase III ARANOTE trial of darolutamide in combination with androgen deprivation therapy in men with metastatic...
Inside information: Orion upgrades full-year outlook for 2024 ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION1 JULY 2024 at...
Orion is developing the Finnish life science industry in a unique collaboration project ORION CORPORATION PRESS RELEASE 03 June 2024 at 09.30...
Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025 ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES...
Orion Corporation: Managers’ transactions – Maziar Mike Doustdar ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST ...
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) ORION CORPORATION STOCK EXCHANGE...
Composition of the Nomination Committee of Orion Corporation ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.